WallStSmart

Equinix Inc (EQIX)vsGlobal Medical REIT Inc. (GMRE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Equinix Inc generates 6294% more annual revenue ($9.26B vs $144.83M). EQIX leads profitability with a 14.6% profit margin vs 0.0%. EQIX appears more attractively valued with a PEG of 4.91. GMRE earns a higher WallStSmart Score of 52/100 (C-).

EQIX

Buy

50

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 2.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.55

GMRE

Buy

52

out of 100

Grade: C-

Growth: 4.0Profit: 4.0Value: 5.7Quality: 3.5
Piotroski: 4/9Altman Z: -0.31
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EQIXSignificantly Overvalued (-38.5%)

Margin of Safety

-38.5%

Fair Value

$626.41

Current Price

$1082.83

$456.42 premium

UndervaluedFair: $626.41Overvalued
GMREUndervalued (+48.1%)

Margin of Safety

+48.1%

Fair Value

$70.88

Current Price

$35.98

$34.90 discount

UndervaluedFair: $70.88Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EQIX3 strengths · Avg: 8.3/10
Market CapQuality
$106.79B9/10

Large-cap with strong market position

Operating MarginProfitability
21.5%8/10

Strong operational efficiency at 21.5%

EPS GrowthGrowth
22.9%8/10

Earnings expanding 22.9% YoY

GMRE1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Areas to Watch

EQIX4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.613/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.912/10

Expensive relative to growth rate

P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

GMRE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
2.0%4/10

2.0% earnings growth

Market CapQuality
$979.78M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : EQIX

The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth.

Bull Case : GMRE

The strongest argument for GMRE centers on Price/Book.

Bear Case : EQIX

The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.6x leaves little room for execution misses. Debt-to-equity of 1.61 is elevated, increasing financial risk.

Bear Case : GMRE

The primary concerns for GMRE are Revenue Growth, EPS Growth, Market Cap. Debt-to-equity of 1.50 is elevated, increasing financial risk. Thin 0.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

GMRE carries more volatility with a beta of 1.20 — expect wider price swings.

EQIX is growing revenue faster at 8.1% — sustainability is the question.

GMRE generates stronger free cash flow (-88M), providing more financial flexibility.

Monitor REIT - SPECIALTY industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GMRE scores higher overall (52/100 vs 50/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Equinix Inc

REAL ESTATE · REIT - SPECIALTY · USA

Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.

Visit Website →

Global Medical REIT Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Global Medical REIT Inc. (GMRE) is a prominent healthcare-focused real estate investment trust (REIT) dedicated to acquiring and leasing income-producing healthcare facilities throughout the United States. By targeting established operators in sectors such as outpatient surgical centers, hospitals, and senior living facilities, GMRE aims to deliver consistent and growing income streams to investors. The company strategically navigates underserved markets, positioning itself to address the increasing demand for healthcare infrastructure while maintaining a diversified tenant base that enhances portfolio resilience and drives sustainable shareholder returns.

Want to dig deeper into these stocks?